课题基金 / 基金详情

STUDY COMPARING STANOZOLOL AND PLACEBO IN PATIENTS WITH CANCER CACHEXIA

STUDY COMPARING STANOZOLOL AND PLACEBO IN PATIENTS WITH CANCER CACHEXIA
康力龙和安慰剂治疗癌症恶病质患者的比较研究
批准号：
5223220
负责人：
JOHN ECKARDT
金额：
$0.0万
依托单位：
--
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/5223220
关键词：
androgen analog appetite body composition body weight cachexia clinical research drug administration rate /duration drug screening /evaluation hormone therapy human subject human therapy evaluation neoplasm /cancer chemotherapy neoplasm /cancer palliative treatment nutrition aspect of cancer quality of life

项目摘要

项目成果

JOHN ECKARDT的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This study will evaluate the effect of placebo versus stanozolol given by mouth daily for twelve weeks to determine its effects on weight gain, appetite, anthropometric parameters, protein status, performance status, body composition and quality of life.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PHASE I OF BCNU AND TEMOZOLOMIDE
PHASE I OF LY309887 IN PATIENTS WITH METASTATIC CANCER
PHASE I STUDY OF TOREMIFENE AND DOXORUBICIN IN PATIENTS WITH ADVANCED CANCER
PHASE I STUDY OF TOREMIFENE AND DOXORUBICIN IN PATIENTS WITH ADVANCED CANCER
海外基金